Loading patent…
AssigneeKM Biologics Co., Ltd.
InventorsMasaharu TORIKAI, Hiroaki MORI, Tomohiro NISHIMURA, Takahiro KATAYAMA, Kohsuke HAZEYAMA, Miyuki MATSUMOTO, Hiroyuki SHIMIZU, Naoki INOUE
Estimating the term…
An object of the present invention is to provide an effective vaccine capable of preventing and treating congenital infection with CMV. The vaccine for preventing or treating congenital infection with cytomegalovirus (CMV) according to the present invention comprises a CMV envelope glycoprotein B (gB protein) antigen and a pentamer antigen.
A vaccine for preventing or treating congenital infection with cytomegalovirus (CMV), comprising a CMV envelope glycoprotein B (gB protein) antigen and a pentamer antigen.
A vaccine kit for preventing or treating congenital infection with human cytomegalovirus (HCMV), comprising:
Use of a human cytomegalovirus (HCMV) envelope glycoprotein B (gB protein) antigen and a pentamer antigen consisting of HCMV gH, gL, UL128, UL130, and UL131, in manufacture of a vaccine or a vaccine kit for preventing or treating congenital infection with HCMV.
Dependencies are inferred from the claim text.